Clinical Trials Logo

Osteochondritis Dissecans clinical trials

View clinical trials related to Osteochondritis Dissecans.

Filter by:

NCT ID: NCT01347892 Active, not recruiting - Clinical trials for Defect of Articular Cartilage

DeNovo NT Ankle LDC Study

Start date: March 2011
Phase: N/A
Study type: Observational

The purpose of this post-market clinical study is to collect long-term outcomes for DeNovo NT Graft treatment of articular cartilage lesions in the ankle in a standard clinical setting. Outcomes to be assessed include pain, function, activity levels and healthcare resource use.

NCT ID: NCT01329445 Active, not recruiting - Clinical trials for Osteochondritis Dissecans

DeNovo NT Longitudinal Data Collection (LDC) Knee Study

Start date: February 2011
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the long-term outcomes of DeNovo NT, a tissue product used for the repair of cartilage damage in the knee. This product has been on the market since 2007 and implanted in more than 10,000 patients around the country.

NCT ID: NCT01283737 Withdrawn - Clinical trials for Osteochondritis Dissecans

Use of Demineralised Bone Matrix (DBX) in Osteochondritis Dissecans (OCD)

Start date: n/a
Phase: Phase 4
Study type: Interventional

This is a 1:1 randomised pilot study in 30 patients in 1 site in Helsinki, Finland. The investigators hypothesize that function, pain, type and quality of cartilage in adult patients with osteochondritis dissecans of the knee will be better in the DBX group compared to the mosaicplasty group.

NCT ID: NCT01159899 Recruiting - Osteoarthritis Clinical Trials

Transplantation of Bone Marrow Stem Cells Stimulated by Proteins Scaffold to Heal Defects Articular Cartilage of the Knee

Start date: July 2010
Phase: Phase 0
Study type: Interventional

The purpose of this pilot study is to investigate the efficacy and safety of autologous transplantation, under arthroscopy, of Bone Marrow Mesenchymal stem cells, using, with a cell separator, a fresh non-culture expanded Autologous Bone Marrow derived Mesenchymal Stem, mixed and activated with proteins scaffold in patient with Knee cartilage defects and osteoarthritis. Based on extensive preclinical investigations, the technology of using freshly isolated bone marrow mononuclear cells mixed with proteins seems safe and most effective for a one-step correction of cartilage defect and restoration of the osteochondral complex, because the same mixture can generate cartilage in the vasculature-free knee joint, and bone in the environment of bone defects.

NCT ID: NCT00881023 Terminated - Clinical trials for Osteochondritis Dissecans

Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration

CAIS
Start date: July 2010
Phase: N/A
Study type: Interventional

The Cartilage Autograft Implantation System (CAIS) is designed as a single surgical treatment of damaged knee cartilage using the subject's own healthy cartilage obtained from a non-weight or low weight-bearing region. CAIS is indicated for the repair of articular cartilage lesions and osteochondritis dissecans (OCD) of the knee through cartilage regeneration.